## Abstract ## **__Purpose.__** To evaluate the use of flash‐echo contrast sonography (FECS) in subtraction mode in assessing small hepatocellular carcinoma (HCC) after percutaneous local ablation therapy. ## **__Methods.__** Between March 2000 and February 2002, we prospectively assessed small
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
✍ Scribed by Margarita Sala; Josep M. Llovet; Ramon Vilana; Lluís Bianchi; Manel Solé; Carmen Ayuso; Concepció Brú; Jordi Bruix
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 147 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: In japan, where liver transplantation has not been used to treat patients with hepatocellular carcinoma (hcc), percutaneous ethanol injection (pei) has been employed for those with small hccs that are not amenable to surgical resection. in the current study, the authors evaluated pei
## Abstract ## BACKGROUND The authors used computed tomography (CT) scans to correlate the changes in tumor vascularity, necrosis, and size with response and survival after transcatheter arterial chemoembolization (TACE) in patients with advanced, unresectable, hepatocellular carcinoma (HCC). ##
Transplantation is the treatment of choice for hepatocellular carcinoma (HCC) meeting the Milan criteria. HCC and chronic liver diseases have distinct natural histories for which an equitable transplant policy must account. We enrolled and prospectively followed at a single center 206 consecutive HC
## Background: The objective of this study was to identify clinical, biochemical, ultrasound, and/or pathologic parameters capable of predicting survival in a cohort of patients with well compensated cirrhosis and small hepatocellular carcinoma (hcc) who were treated with percutaneous ethanol injec